Development and Optimization of Rizatriptan Benzoate-Loaded Ethosomal Thermosensitive In-Situ Nasal Gel for Brain-Targeted Migraine Therapy
Journal of Pharmaceutical Innovation · 2026-06 · 21 (3)
DOI: 10.1007/s12247-026-10522-0 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmaceutical Innovation, online erschienen am 02.03.2026. Verfasst von Judy Fernandes und 4 weiteren Autor:innen. Die Arbeit nennt 31 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Fernandes, J., Parab, A., Krishna, M., Mali, A., & Chellampillai, B. (2026). Development and Optimization of Rizatriptan Benzoate-Loaded Ethosomal Thermosensitive In-Situ Nasal Gel for Brain-Targeted Migraine Therapy. Journal of Pharmaceutical Innovation, 21(3). https://doi.org/10.1007/s12247-026-10522-0
Vancouver
Fernandes J, Parab A, Krishna M, Mali A, Chellampillai B. Development and Optimization of Rizatriptan Benzoate-Loaded Ethosomal Thermosensitive In-Situ Nasal Gel for Brain-Targeted Migraine Therapy. Journal of Pharmaceutical Innovation. 2026;21(3). doi:10.1007/s12247-026-10522-0
BibTeX
@article{Fernandes2026,
author = {Fernandes, Judy and Parab, Asma and Krishna, Mythili and Mali, Ashwin and Chellampillai, Bothiraja},
title = {Development and Optimization of Rizatriptan Benzoate-Loaded Ethosomal Thermosensitive In-Situ Nasal Gel for Brain-Targeted Migraine Therapy},
journal = {Journal of Pharmaceutical Innovation},
year = {2026},
volume = {21},
number = {3},
doi = {10.1007/s12247-026-10522-0}
}
EUVIMED